Patrick Aisher is the Chairman of Kinled Holding Limited, a private investment company recognized by the Financial Times as one of Europe’s leading health-tech investors. They have cultivated a diverse portfolio of over 130 investments, with significant involvement in life science, digital, and financial technology sectors. Aisher also serves as Director at Bricksave and Aleva Neurotherapeutics, and is the Chairman of both Danube BioVentures and PreComb Therapeutics. Additionally, they hold board positions at various innovative biotech companies, contributing to advancements in personalized cancer treatments and medical devices. Aisher's education includes specialized training in trust law from the Society of Trust & Estate Professionals.
This person is not in the org chart
This person is not in any teams
This person is not in any offices